UK Antibodies Supply Tender

UK Antibodies Supply Tender

Demand for antibody prophylaxis is estimated at up to 1.5 million 1 g doses of an antibody cocktail.

United Kingdom-London: Pharmaceutical products

2020/S 205-500529

Prior information notice

This notice aims at reducing time limits for receipt of tenders

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: The Department for Business, Energy and Industrial Strategy (BEIS)
Postal address: 1 Victoria Street
Town: London
NUTS code: UK UNITED KINGDOM
Postal code: SW1H 0ET
Country: United Kingdom
Contact person: Raaj K Bhatti
E-mail: abstender@beis.gov.uk
Telephone: +44 7585992946
Internet address(es):
Main address: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy

I.3)Communication

Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

General public services

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

UK Antibodies Supply

 

II.1.2)Main CPV code

33600000 Pharmaceutical products

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Covid-19 requires over 500 000 ‘at risk’ people in the UK to be protected via antibody prophylaxis as they are unlikely to benefit from a vaccine. Demand for antibody prophylaxis is estimated at up to 1.5 million 1 g doses of an antibody cocktail (containing two antibodies at 0.5 g each) per annum. Current UK manufacturing supply chains do not have capacity to produce these levels. To secure this and ensure the UK is best placed to respond to future requirements, by assuring supply chain resilience and access, the Department is seeking to engage the market to explore how UK antibody manufacturing capability can be developed. The target is for capability to reach 1.5 m 1 g doses of antibody cocktail pa under Good Manufacturing Process by the end of Q2 2022.

 

II.1.5)Estimated total value

Value excluding VAT: 1.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM
Main site or place of performance:

UNITED KINGDOM

 

II.2.4)Description of the procurement:

There is a need to explore how UK antibody manufacturing capability can be developed to deliver supply chain resilience and secure access to 1.5 million doses of a 1 g antibody cocktail. Specifically, the Department is interested in engaging with the market prior to the publication of the contract notice to find innovative solutions that could deliver the service and further inform the specification of requirements, conditions of contract and commercial model. Further details of how suppliers may participate in the market engagement exercise are included in section VI.3) (additional information) at the end of this notice.

 

II.2.5)Award criteria

Criteria below
Quality criterion – Name: High level technical split / Weighting: 70
Cost criterion – Name: High level commercial split / Weighting: 30

II.2.6)Estimated value

Value excluding VAT: 1.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

II.2.10)Information about variants

Variants will be accepted
II.2.11)Information about options

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Please refer to detailed additional information at section VI).

 

II.3)Estimated date of publication of contract notice:

18/12/2020

Section IV: Procedure

IV.1)Description
IV.1.3)Information about a framework agreement or a dynamic purchasing system

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.5)Scheduled date for start of award procedures:

Section VI: Complementary information

VI.2)Information about electronic workflows

Electronic ordering will be used
Electronic payment will be used

VI.3)Additional information:

 

The Department wishes to engage with the market prior to the publication of the contract notice to find innovative solutions that could deliver the enduring demand and further inform the specification of requirements, conditions of contract and commercial model.

Interested parties will be able to explore and clarify understanding of the requirement through a virtual market engagement event (Monday 26 October). Post event the Department welcomes feedback from interested parties via a questionnaire where areas of interest include (but are not limited to):

• provision of a value for money solution for the UK tax payer;

• investment by a potential supplier in developing antibody manufacturing in the UK;

• investment, in part or in full, by Her Majesty’s Government (HMG) in developing antibody manufacturing in the UK with a commercial operator;

• creating mechanisms (including but not limited to agreements) to secure long-term, guaranteed supply contracts with ‘step-in’ rights in the event of future pandemics.

When responding to this notice, please advise if you will be attending the event and provide contact information for your representatives, (maximum three per organisation). Responses should be sent to abstender@beis.gov.uk by 5 p.m. UK time, Friday 23 October.

Next steps and key dates:

— Friday 23 October:

Deadline to register for this market engagement phase which will be via the Microsoft Teams platform. The agenda and protocols will be provided to all participants prior to the 26 October. The event will be recorded for transparency and audit purposes.

— Monday 26 October:

(Virtual) market event held. Post event the Department will issue the questionnaire to interested parties.

— Friday 6 November:

Deadline for submission of completed questionnaires.

— December:

The anticipated launch of a potential procurement action (including the contract notice) is expected in December.

For further information or any enquiries on the above please contact abstender@beis.gov.uk

Disclaimer:

This notice is for information only, and the Department reserves the right to supplement and vary the conduct of the prior engagement process. Where this occurs, the Department will act transparently and treat all interested parties who have expressed an interest equally.

The Department reserves the right to discontinue the proposed tendering process and not award the contract. The information contained in this notice, including information relating to the nature and scope of the Department’s requirements, the service classification of this requirement or the list of CPV codes, is only indicative of the Department’s current thinking and is neither exhaustive nor binding. The Department reserves the right at its absolute discretion to amend it at the time of issue of any further notices or at any other time.

The publication of this notice in no way obliges the Department to commence with any competitive tender process. The Department is not and shall not be liable for any costs incurred by those expressing any interest in participating in the market engagement exercise advertised in this notice.

To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=535012293

Go reference: GO-20201016-PRO-17234012

 

VI.4)Procedures for review

VI.4.1)Review body

Official name: The Department for Business, Energy and Industrial Strategy (BEIS)
Postal address: 1 Victoria Street
Town: London
Postal code: SW1H 0ET
Country: United Kingdom

VI.5)Date of dispatch of this notice:

16/10/2020